United Maritime Capital’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
United Maritime Capital's MRNA Position: Q2 2022 in Review
United Maritime Capital sold out of Moderna (MRNA) in Q2 2022, closing a stake of 7,700 shares — an estimated $1.33M sold.
United Maritime Capital first reported a position in MRNA in Q3 2021 and held it in 3 quarters. The position peaked at $1.96M in Q4 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.
- United Maritime Capital reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
- United Maritime Capital sold 7,700 Moderna shares in Q2 2022, an estimated $1.33M.
- United Maritime Capital first reported a position in Moderna in Q3 2021 and held it in 3 quarters.
- United Maritime Capital's Moderna position peaked at $1.96M in Q4 2021.
- 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.
Based on United Maritime Capital's 13F filing for Q2 2022, filed 12 Aug 2022.